We are live on
!
Find out more
Dianthus Therapeutics
DNTH
DNTH
74 hedge funds and large institutions have $769M invested in Dianthus Therapeutics in 2024 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 19 increasing their positions, 16 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
19% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 16
17% more funds holding in top 10
Funds holding in top 10: 6 → 7 (+1)
12.35% more ownership
Funds ownership: 88.85% → 101.2% (+12%)
2% less capital invested
Capital invested by funds: $782M → $769M (-$13.5M)
7% less first-time investments, than exits
New positions opened: 28 | Existing positions closed: 30
3% less funds holding
Funds holding: 76 → 74 (-2)
Holders
74
Holders Change
-2
Holders Change %
-2.63%
% of All Funds
1.07%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.1%
New
28
Increased
19
Reduced
16
Closed
30
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BlackRock
New York
|
+$37.4M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$17M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$10.2M |
| 4 |
State Street
Boston,
Massachusetts
|
+$9.31M |
| 5 |
B
Braidwell
Stamford,
Connecticut
|
+$8.82M |
Top Sellers
| 1 |
Millennium Management
New York
|
-$8.32M |
| 2 |
ABG
Ally Bridge Group
New York
|
-$6.51M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$6.16M |
| 4 |
Walleye Capital
New York
|
-$5.71M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$4.28M |
